评估乳房肿块

American Cancer Society. Breast cancer facts and figures 2017-2018. 2017 [internet publication].

• 全文

Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994 Jul 7;331(1):10-5.

• 全文
• 摘要

Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51.

• 摘要

American College of Radiology. ACR appropriateness criteria: palpable breast masses. 2016 [internet publication].

• 全文

Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography: a meta-analysis. JAMA. 1995 Jan 11;273(2):149-54.

• 摘要

American College of Radiology. ACR practice parameter for the performance of ultrasound-guided percutaneous breast interventional procedures. 2016 [internet publication].

• 全文

1.  Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999 Apr 20;130(8):651-7.

• 摘要

2.  Beyer T, Moonka R. Normal mammography and ultrasonography in the setting of palpable breast cancer. Am J Surg. 2003 May;185(5):416-9.

• 摘要

3.  Vetto JT, Pommier RF, Schmidt WA, et al. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective. Arch Surg. 1996 Sep;131(9):967-72.

• 摘要

4.  Vetto JT, Pommier RF, Schmidt WA, et al. Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings. Am J Surg. 1995 May;169(5):519-22.

• 摘要

5.  Morris A, Pommier RF, Schmidt WA, et al. Accurate evaluation of palpable breast masses by the triple test score. Arch Surg. 1998 Sep;133(9):930-4.

• 全文
• 摘要

6.  American Cancer Society. Breast cancer facts and figures 2017-2018. 2017 [internet publication].

• 全文

7.  Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2017, with focus on lung cancer. Ann Oncol. 2017 May 1;28(5):1117-23.

• 全文
• 摘要

8.  Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015 Sep;26(suppl 5):v8-30.

• 全文
• 摘要

9.  Dent DM, Cant PJ. Fibroadenoma. World J Surg. 1989 Nov-Dec;13(6):706-10.

• 摘要

10.  Martin PM, Kuttenn F, Serment H, et al. Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem. 1978 Dec;9(12):1251-5.

• 摘要

11.  Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994 Jul 7;331(1):10-5.

• 全文
• 摘要

12.  Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic benign breast disease cohort study. Breast Cancer Res Treat. 2015 Sep;153(2):397-405.

• 全文
• 摘要

13.  Stamatakos M, Tsaknaki S, Kontzoglou K, et al. Phylloides tumor of the breast: a rare neoplasm, though not that innocent. Int Semin Surg Oncol. 2009 Feb 20;6:6.

• 全文
• 摘要

14.  Miltenburg DM, Speights VO Jr. Benign breast disease. Obstet Gynecol Clin North Am. 2008 Jun;35(2):285-300.

• 摘要

15.  Giri D. Recurrent challenges in the evaluation of fibroepithelial lesions. Arch Pathol Lab Med. 2009 May;133(5):713-21.

• 全文
• 摘要

16.  Frantz VK, Pickren JW, Melcher GW, et al. Incidence of chronic cystic disease in so-called "normal" breasts; a study based on 225 postmortem examinations. Cancer. 1951 Jul;4(4):762-83.

• 摘要

17.  Ross RK, Paganini-Hill A, Wan PC, et al. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000 Feb 16;92(4):328-32.

• 全文
• 摘要

18.  Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995 Jul;196(1):123-34.

• 摘要

19.  Houssami N, Irwig L, Ung O. Review of complex breast cysts: implications for cancer detection and clinical practice. ANZ J Surg. 2005 Dec;75(12):1080-5.

• 摘要

20.  National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis [internet publication].

• 全文

21.  Baker TP, Lenert JT, Parker J, et al. Lactating adenoma: a diagnosis of exclusion. Breast J. 2001 Sep-Oct;7(5):354-7.

• 摘要

22.  Beute BJ, Kalisher L, Hutter RV. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR Am J Roentgenol. 1991 Aug;157(2):257-65.

• 全文
• 摘要

23.  Winchester DP, Jeske JM, Goldschmidt RA. The diagnosis and management of ductal carcinoma in-situ of the breast. CA Cancer J Clin. 2000 May-Jun;50(3):184-200.

• 全文
• 摘要

24.  Public Health England. NHS breast screening programme clinical guidance for breast cancer screening assessment. November 2016 [internet publication].

• 全文

25.  Winchester DJ, Bernstein JR, Jeske JM, et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg. 2003 Jun;138(6):619-22.

• 全文
• 摘要

26.  Guth U, Huang DJ, Huber M, et al. Tumor size and detection in breast cancer: self-examination and clinical breast examination are at their limit. Cancer Detect Prev. 2008;32(3):224-8.

• 摘要

27.  Breen N, Yabroff KR, Meissner HI. What proportion of breast cancers are detected by mammography in the United States? Cancer Detect Prev. 2007;31(3):220-4.

• 摘要

28.  Benson JR, Jatoi I, Keisch M, et al. Early breast cancer. Lancet. 2009 Apr 25;373(9673):1463-79.

• 摘要

29.  Lynch HT, Silva E, Snyder C, et al. Hereditary breast cancer - part I: diagnosing hereditary breast cancer syndromes. Breast J. 2008 Jan-Feb;14(1):3-13.

• 摘要

30.  Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51.

• 摘要

31.  Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):297-301.

• 全文
• 摘要

32.  Sakorafas GH, Krespis E, Pavlakis G. Risk estimation for breast cancer development; a clinical perspective. Surg Oncol. 2002 May;10(4):183-92.

• 摘要

33.  National Institute for Health and Care Excellence. Menopause: diagnosis and management. November 2015 [internet publication].

• 全文

34.  de Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013 Apr;16(2):203-4.

• 摘要

35.  de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Climacteric. 2016 Aug;19(4):313-5.

• 摘要

36.  Shapley M, Mansell G, Jordan JL, et al. Positive predictive values of ≥5% in primary care for cancer: systematic review. Br J Gen Pract. 2010 Sep;60(578):e366-77.

• 摘要

37.  Hindle WH. Breast mass evaluation. Clin Obstet Gynecol. 2002 Sep;45(3):750-7.

• 摘要

38.  Goodson WH 3rd, Hunt TK, Plotnik JN, et al. Optimization of clinical breast examination. Am J Med. 2010 Apr;123(4):329-34.

• 摘要

39.  Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877.

• 全文
• 摘要

40.  Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010 Jan;7(1):18-27.

• 全文
• 摘要

41.  Siu AL; US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2016 Feb 16;164(4):279-96.

• 全文
• 摘要

42.  American College of Radiology. ACR appropriateness criteria: palpable breast masses. 2016 [internet publication].

• 全文

43.  Malur S, Wurdinger S, Moritz A, et al. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res. 2001;3(1):55-60.

• 全文
• 摘要

44.  Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography: a meta-analysis. JAMA. 1995 Jan 11;273(2):149-54.

• 摘要

45.  Kacl GM, Liu P, Debatin JF, et al. Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging. Eur Radiol. 1998;8(2):194-200.

• 摘要

46.  Bone B, Pentek Z, Perbeck L, et al. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol. 1997 Jul;38(4 pt 1):489-96.

• 摘要

47.  Kerlikowske K, Smith-Bindman R, Ljung BM, et al. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003 Aug 19;139(4):274-84.

• 摘要

48.  Cox B, Ballard-Barbash R, Broeders M, et al; International Cancer Screening Network. Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network. Breast Cancer Res Treat. 2010 Dec;124(3):793-800.

• 摘要

49.  Woods RW, Sisney GS, Salkowski LR, et al. The mammographic density of a mass is a significant predictor of breast cancer. Radiology. 2011 Feb;258(2):417-25.

• 摘要

50.  American College of Radiology. ACR practice parameter for the performance of a breast ultrasound examination. 2016 [internet publication].

• 全文

51.  Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002 Oct;225(1):165-75.

• 全文
• 摘要

52.  Max MH, Klamer TW. Breast cancer in 120 women under 35 years old: a 10-year community-wide survey. Am Surg. 1984 Jan;50(1):23-5.

• 摘要

53.  American College of Radiology. ACR practice parameter for the performance of ultrasound-guided percutaneous breast interventional procedures. 2016 [internet publication].

• 全文

54.  Gong X, Xu Q, Xu Z, et al. Real-time elastography for the differentiation of benign and malignant breast lesions: a meta-analysis. Breast Cancer Res Treat. 2011 Nov;130(1):11-8.

• 摘要

55.  Sadigh G, Carlos RC, Neal CH, et al. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring. Breast Cancer Res Treat. 2012 May;133(1):23-35.

• 摘要

56.  Sadigh G, Carlos RC, Neal CH, et al. Accuracy of quantitative ultrasound elastography for differentiation of malignant and benign breast abnormalities: a meta-analysis. Breast Cancer Res Treat. 2012 Aug;134(3):923-31.

• 摘要

57.  Medeiros LR, Duarte CS, Rosa DD, et al. Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis. Breast Cancer Res Treat. 2011 Apr;126(2):273-85.

• 摘要

58.  Lehman CD, DeMartini W, Anderson BO, et al. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009 Feb;7(2):193-201.

• 摘要

59.  Lee JM, Halpern EF, Rafferty EA, Gazelle GS. Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk. Acad Radiol. 2009 Nov;16(11):1323-8.

• 摘要

60.  Flamm CR, Ziegler KM, Aronson N. Technology Evaluation Center assessment synopsis: use of magnetic resonance imaging to avoid a biopsy in women with suspicious primary breast lesions. J Am Coll Radiol. 2005 Jun;2(6):485-7.

• 摘要

61.  Peters NH, Borel Rinkes IH, Zuithoff NP, et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008 Jan;246(1):116-24.

• 全文
• 摘要

62.  Chen X, Li WL, Zhang YL, et al. Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer. 2010 Dec 29;10:693.

• 全文
• 摘要

63.  Dorrius MD, Jansen-van der Weide MC, van Ooijen PM, et al. Computer-aided detection in breast MRI: a systematic review and meta-analysis. Eur Radiol. 2011 Aug;21(8):1600-8.

• 全文
• 摘要

64.  Escalona S, Blasco JA, Reza MM, et al. A systematic review of FDG-PET in breast cancer. Med Oncol. 2010 Mar;27(1):114-29.

• 摘要

65.  Samson DJ, Flamm CR, Pisano ED, Aronson N. Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy? Acad Radiol. 2002 Jul;9(7):773-83.

• 摘要

66.  Xu HB, Li L, Xu Q. Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression. Nucl Med Commun. 2011 Nov;32(11):980-8.

• 摘要

67.  Akçil M, Karaağaoğlu E, Demirhan B. Diagnostic accuracy of fine-needle aspiration cytology of palpable breast masses: an SROC curve with fixed and random effects linear meta-regression models. Diagn Cytopathol. 2008 May;36(5):303-10.

• 摘要

68.  Yu YH, Wei W, Liu JL. Diagnostic value of fine-needle aspiration biopsy for breast mass: a systematic review and meta-analysis. BMC Cancer. 2012 Jan 25;12:41.

• 全文
• 摘要

69.  Yu YH, Liang C, Yuan XZ. Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review. Breast Cancer Res Treat. 2010 Apr;120(2):469-79.

• 摘要

70.  National Institute for Health and Care Excellence. Image-guided radiofrequency excision biopsy of breast lesions. July 2009 [internet publication].

• 全文

71.  Hahn M, Krainick-Strobel U, Toellner T, et al. Interdisciplinary consensus recommendations for the use of vacuum-assisted breast biopsy under sonographic guidance: first update 2012. Ultraschall Med. 2012 Aug;33(4):366-71.

• 摘要

72.  Hindle WH, Arias RD, Florentine B, et al. Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts. Am J Obstet Gynecol. 2000 Jun;182(6):1300-5.

• 摘要